CONMED Corp (CNMD) stock
CNMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 14/3028% below fair value
$46.56+0.18 (+0.39%)
Close on Nov 20, 2026Market cap $1.39BP/E 19.2Yield 1.29%
Conmed gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Conmed's gross profit for the twelve months ending Sep 30, 2026 was $788.34M, up 7.9% year over year. For fiscal 2025 it was $750.48M, up 2.4% from the year before. Over ten years it grew 7.0% a year on average. The highest annual figure on record is $750.48M in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $750.48M | +2.4% |
| FY2024 | Dec 31, 2024 | $733.03M | +8.4% |
| FY2023 | Dec 31, 2023 | $676.25M | +18.4% |
| FY2022 | Dec 31, 2022 | $571.25M | +0.6% |
| FY2021 | Dec 31, 2021 | $568.04M | +23.4% |
| FY2020 | Dec 31, 2020 | $460.30M | -12.3% |
| FY2019 | Dec 31, 2019 | $524.72M | +11.9% |
| FY2018 | Dec 31, 2018 | $469.11M | +8.8% |
| FY2017 | Dec 31, 2017 | $431.04M | +5.6% |
| FY2016 | Dec 31, 2016 | $408.33M | +7.0% |
| FY2015 | Dec 31, 2015 | $381.70M | -5.5% |
| FY2014 | Dec 31, 2014 | $404.06M | -2.0% |
| FY2013 | Dec 31, 2013 | $412.42M | +1.6% |
| FY2012 | Dec 31, 2012 | $405.84M | +8.2% |
| FY2011 | Dec 31, 2011 | $374.93M | +2.6% |
| FY2010 | Dec 31, 2010 | $365.38M | +8.3% |
| FY2009 | Dec 31, 2009 | $337.33M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $189.15M | +13.9% |
| Q2 FY2026 | Jun 30, 2026 | $197.46M | +4.9% |
| Q1 FY2026 | Mar 31, 2026 | $183.45M | +3.2% |
| Q4 FY2025 | Dec 31, 2025 | $218.29M | +10.1% |
| Q3 FY2025 | Sep 30, 2025 | $166.12M | -7.2% |
| Q2 FY2025 | Jun 30, 2025 | $188.32M | +2.5% |
| Q1 FY2025 | Mar 31, 2025 | $177.75M | +3.4% |
| Q4 FY2024 | Dec 31, 2024 | $198.34M | +8.9% |
| Q3 FY2024 | Sep 30, 2024 | $179.00M | +6.5% |
| Q2 FY2024 | Jun 30, 2024 | $183.73M | +7.6% |
| Q1 FY2024 | Mar 31, 2024 | $171.97M | +10.7% |
| Q4 FY2023 | Dec 31, 2023 | $182.18M | +38.2% |
| Q3 FY2023 | Sep 30, 2023 | $168.06M | +10.8% |
| Q2 FY2023 | Jun 30, 2023 | $170.69M | +12.5% |
| Q1 FY2023 | Mar 31, 2023 | $155.32M | +14.2% |
| Q4 FY2022 | Dec 31, 2022 | $131.86M | -15.4% |
| Q3 FY2022 | Sep 30, 2022 | $151.62M | +6.5% |
| Q2 FY2022 | Jun 30, 2022 | $151.78M | +7.3% |
| Q1 FY2022 | Mar 31, 2022 | $135.99M | +5.9% |
| Q4 FY2021 | Dec 31, 2021 | $155.86M | +15.0% |
| Q3 FY2021 | Sep 30, 2021 | $142.31M | +6.4% |
| Q2 FY2021 | Jun 30, 2021 | $141.42M | +96.6% |
| Q1 FY2021 | Mar 31, 2021 | $128.45M | +7.8% |
| Q4 FY2020 | Dec 31, 2020 | $135.51M | -4.6% |
| Q3 FY2020 | Sep 30, 2020 | $133.70M | +2.8% |
| Q2 FY2020 | Jun 30, 2020 | $71.93M | -45.2% |
| Q1 FY2020 | Mar 31, 2020 | $119.16M | -1.9% |
| Q4 FY2019 | Dec 31, 2019 | $141.98M | +7.0% |
| Q3 FY2019 | Sep 30, 2019 | $130.11M | +17.6% |
| Q2 FY2019 | Jun 30, 2019 | $131.19M | +12.8% |
| Q1 FY2019 | Mar 31, 2019 | $121.44M | +10.8% |
| Q4 FY2018 | Dec 31, 2018 | $132.66M | +7.0% |
| Q3 FY2018 | Sep 30, 2018 | $110.63M | +7.9% |
| Q2 FY2018 | Jun 30, 2018 | $116.27M | +11.1% |
| Q1 FY2018 | Mar 31, 2018 | $109.56M | +9.7% |
| Q4 FY2017 | Dec 31, 2017 | $123.96M | +15.9% |
| Q3 FY2017 | Sep 30, 2017 | $102.55M | – |
| Q2 FY2017 | Jun 30, 2017 | $104.65M | – |
| Q1 FY2017 | Mar 31, 2017 | $99.89M | – |
| Q4 FY2016 | Dec 31, 2016 | $106.96M | – |
See a number that looks wrong?